This page contains big data tables. Please visit the desktop version for a complete experience.
| Area of specialization | Product | Indication | Current status | Next milestones |
|---|---|---|---|---|
| Pharmaceutical technologies | Biosimilar | Oncological | h2h Biosimilarity Study | Completion of 2h2 |
| Injectable lyophilized* | Fungic infection | Validations | Manufacture of registration lots | |
| Injectable* | Bacterial infections | Validations | Manufacture of registration lots | |
| Injectable* | Neuromuscular blockade | Registry | DCP Registration phase | |
| Injectable* | Heart failure | Registry | DCP Registration phase | |
| Veterinary Amoxicillin / Clavulanic* | Bacterial infections | Bioequivalence Assay | Start bioequivalence test |
* Out of patent
| Area of specialization | Product | Indication | Current status | Next milestones |
|---|---|---|---|---|
| Specialty pharmacare | P-265 | Topical antiinfective | Internacionalization phase | |
| Impetine ® | Impetigo | In registration phase Spain & DCP | ||
| Food supplement | Strengthen immune system | European registry | Completion of the COVID-19 risk study | |
| Cosmetic range | Acne | Clinical study | Start clinical study |